News Johnson & Johnson Reports the US FDA’s Approval of Rybrevant + Lazcluze as a 1L Treatment of NSCLC with EGFR Mutations ByDipanshu DixitAugust 19, 20240Comments
THOUGHTSPOT What are the Top Locations for Locum Tenens Cardiology Jobs in the United States?ByEvans JamesAugust 16, 20240Comments
News Bio-Thera Solutions Expands its Partnership with Pharmapark for BAT2306 (Biosimilar, Cosentyx) Across Russia and Other CountriesByDipanshu DixitAugust 16, 20240Comments
News EMA Accepted the Marketing Application of Alvotech’s AVT06 a Biosimilar of Eylea (aflibercept) ByDipanshu DixitAugust 15, 20240Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in July 2024ByDipanshu DixitAugust 14, 20240Comments
News Incyte and Syndax Receives US FDA Approval for Niktimvo (axatilimab-csfr) to Treat Chronic Graft-Versus-Host Disease (GvHD) ByDipanshu DixitAugust 14, 20240Comments
News US FDA Grants Accelerated Approval to Gilead’s Livdelzi (Seladelpar) to Treat Primary Biliary Cholangitis (PBC) ByDipanshu DixitAugust 14, 20240Comments
